IL33 and asthma: The release of IL‐33 is considered to occur early after exposure to allergens, and its levels are significantly increased in bronchial epithelial cells, airway smooth muscle, bronchoalveolar lavage fluid (BALF), and peripheral blood circulation of patients with asthma, showing a correlation with the severity of asthma [25–27].